MSTN and sarcopenia: The inhibition of the MSTN pathway has become an attractive therapeutic strategy for stimulating muscle growth and/or preventing muscle wasting in many muscle‐wasting diseases, including sarcopenia, comprehensively reviewed in ref. 2.